These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37877001)

  • 1. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.
    Ciani O; Manyara AM; Davies P; Stewart D; Weir CJ; Young AE; Blazeby J; Butcher NJ; Bujkiewicz S; Chan AW; Dawoud D; Offringa M; Ouwens M; Hróbjartssson A; Amstutz A; Bertolaccini L; Bruno VD; Devane D; Faria CDCM; Gilbert PB; Harris R; Lassere M; Marinelli L; Markham S; Powers JH; Rezaei Y; Richert L; Schwendicke F; Tereshchenko LG; Thoma A; Turan A; Worrall A; Christensen R; Collins GS; Ross JS; Taylor RS
    EClinicalMedicine; 2023 Nov; 65():102283. PubMed ID: 37877001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.
    Manyara AM; Davies P; Stewart D; Weir CJ; Young A; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
    BMJ Open; 2022 Oct; 12(10):e064304. PubMed ID: 36220321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.
    Manyara AM; Davies P; Stewart D; Wells V; Weir C; Young A; Taylor R; Ciani O
    BMJ Open; 2022 Oct; 12(10):e062798. PubMed ID: 36229145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate endpoints in trials: a call for better reporting.
    Ciani O; Manyara AM; Chan AW; Taylor RS;
    Trials; 2022 Dec; 23(1):991. PubMed ID: 36503559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
    Manyara AM; Davies P; Stewart D; Weir CJ; Young AE; Wells V; Blazeby J; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
    J Clin Epidemiol; 2023 Aug; 160():83-99. PubMed ID: 37380118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial is not a pilot trial simply because it uses a surrogate endpoint.
    Campbell MJ; Lancaster GA; Eldridge SM
    Pilot Feasibility Stud; 2018; 4():130. PubMed ID: 30069309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
    Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
    Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
    Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
    JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.
    Speich B; Mann E; Schönenberger CM; Mellor K; Griessbach AN; Dhiman P; Gandhi P; Lohner S; Agarwal A; Odutayo A; Puebla I; Clark A; Chan AW; Schlussel MM; Ravaud P; Moher D; Briel M; Boutron I; Schroter S; Hopewell S
    JAMA Netw Open; 2023 Jun; 6(6):e2317651. PubMed ID: 37294569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials.
    Bikdeli B; Caraballo C; Welsh J; Ross JS; Kaul S; Stone GW; Krumholz HM
    Clin Trials; 2020 Dec; 17(6):723-728. PubMed ID: 32838556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.